Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04165941
What this trial is testing

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain Tumor Adult
University of Alabama at Birmingham 22
Testing effectiveness (Phase 2)Study completedNCT00085566
What this trial is testing

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Who this might be right for
Brain and Central Nervous System TumorsProstate Cancer
Memorial Sloan Kettering Cancer Center 61
Testing effectiveness (Phase 2)Looking for participantsNCT07569042
What this trial is testing

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Malignant Neoplasm of Brain
Novelwise Pharmaceutical Corporation 15
Early research (Phase 1)Active Not RecruitingNCT02062827
What this trial is testing

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Who this might be right for
Recurrent Glioblastoma MultiformeProgressive Glioblastoma MultiformeAnaplastic Astrocytoma or Gliosarcoma
University of Alabama at Birmingham 29
Not applicableLooking for participantsNCT06466031
What this trial is testing

Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]

Who this might be right for
Glioblastoma Multiforme
Copernicus Memorial Hospital 189
Testing effectiveness (Phase 2)Study completedNCT00612430
What this trial is testing

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Duke University 59
Testing effectiveness (Phase 2)Study completedNCT00005081
What this trial is testing

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Study completedNCT00329719
What this trial is testing

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 115
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Early research (Phase 1)Study completedNCT01180816
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 21
Early research (Phase 1)Study completedNCT00613132
What this trial is testing

Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Annick Desjardins 78
Early research (Phase 1)Looking for participantsNCT05460507
What this trial is testing

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Who this might be right for
Glioma
Cerenome 40
Early research (Phase 1)Study completedNCT00004041
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT04845919
What this trial is testing

Sonodynamic Therapy With ExAblate System in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 5
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Not applicableTemporarily pausedNCT03322813
What this trial is testing

ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma

Who this might be right for
Glioma
InSightec 15
Early research (Phase 1)WithdrawnNCT02055196
What this trial is testing

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00004024
What this trial is testing

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute 60
Early research (Phase 1)Study completedNCT01682746
What this trial is testing

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 5
Testing effectiveness (Phase 2)Study completedNCT01520870
What this trial is testing

Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.

Who this might be right for
GlioblastomaBrain Tumor, Recurrent
Grupo Español de Investigación en Neurooncología 49
Next Page